Reliance Global Group, Inc.
EZRA Nasdaq Insurance Agents, Brokers & Service Financials FY2019βFY2025
What Reliance Global Group, Inc. does
No business description yet.
- Legal name
- Reliance Global Group, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 10, 2026
- Accession Β· CIK
- 0001493152-26-009536
0001812727
Revenue and margins
Reliance Global Group, Inc. had $12.4M of revenue in fiscal 2025, down 11.6% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$3.1M in fiscal 2025, β25.0% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Reliance Global Group, Inc. returned $0.4M to shareholders in fiscal 2025. The diluted share count rose 441.4%.
Balance sheet
Cash, debt and the ratios that show how comfortably Reliance Global Group, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $4.1M | $0.5M | $1.3M | $0.4M | $1.3M |
| Debt incl. finance leases | $8.0M | $13.6M | $12.5M | $11.1M | $5.2M |
| Debt / equity | β | 1.5x | 1.7x | 3.7x | 0.8x |
| Interest coverage | β | β | β | β | β8.6x |
| Current ratio | 0.2x | 0.4x | 1.4x | 1.1x | 1.8x |
| Quick ratio | 0.2x | 0.4x | 1.4x | 1.1x | 1.8x |
| Total assets | $27.7M | $38.4M | $23.0M | $17.3M | $13.5M |
| Total liabilities | $53.7M | $29.5M | $15.9M | $14.3M | $7.1M |
| Shareholders' equity | β$26.1M | $8.9M | $7.1M | $3.0M | $6.4M |
| Net debt (β = net cash) | $3.9M | $13.1M | $11.1M | $10.7M | $3.8M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β |
| F-score | β / 3 | 5 / 8 | 3 / 8 | 3 / 8 | 4 / 8 | 2 / 8 | 5 / 8 |
| Accruals ratio | β18.4% | β18.3% | β82.4% | 29.2% | β36.3% | β32.5% | β25.2% |
| Altman Z'' | β4.42 | β5.57 | β13.93 | β3.90 | β8.77 | β11.66 | β15.86 |
7 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | $4.5M | $7.3M | $9.7M | $11.8M | $13.7M | $14.1M | $12.4M |
| Operating income | β$3.1M | β$3.6M | β$2.9M | β$6.6M | β$13.9M | β$7.7M | β$9.0M |
| Interest expense | β | β | β | β | β | β | $1.0M |
| Pretax income | β | β | β | β | β | β$9.1M | β$7.0M |
| Net income | β$3.5M | β$3.7M | β$21.1M | $6.5M | β$12.0M | β$9.1M | β$7.0M |
| Net income to common | β | β | β | β | β | β$9.1M | β$7.0M |
| Diluted EPS | β$1.21 | β$0.88 | β$2.09 | β$0.42 | β$87.70 | β$9.01 | β$1.28 |
| Diluted shares | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.01B |
| Cash flow | |||||||
| Cash from operations | β$0.4M | β$0.5M | β$2.3M | β$3.2M | β$0.8M | β$2.5M | β$3.1M |
| Capital expenditure | $0.6M | β | $0.1M | $0.1M | $0.0M | $0.0M | $0.0M |
| Free cash flow | β$0.9M | β | β$2.3M | β$3.3M | β$0.9M | β$2.5M | β$3.1M |
| Depreciation and amortization | $0.7M | $1.3M | $1.6M | $2.6M | $2.6M | $1.8M | $1.3M |
| Stock-based compensation | $1.0M | $1.5M | $0.7M | $1.2M | $0.9M | $0.5M | $4.8M |
| Acquisitions | $11.3M | $0.6M | $1.6M | $6.0M | β | β | β |
| Dividends paid | β | β | β | β | β | β | $0.4M |
| Dividends and buybacks | β | β | β | β | β | β | $0.4M |
| Balance sheet | |||||||
| Cash and short-term investments | $0.0M | $0.5M | $4.1M | $0.5M | $1.3M | $0.4M | $1.3M |
| Total debt | $9.3M | $8.8M | $8.0M | $13.6M | $12.5M | $11.1M | $5.2M |
| Current assets | $0.6M | $1.4M | $8.0M | $3.3M | $4.4M | $4.0M | $4.3M |
| Current liabilities | $4.7M | $6.9M | $45.0M | $7.8M | $3.2M | $3.6M | $2.4M |
| Property and equipment, net | $0.6M | $0.1M | $0.1M | $0.2M | $0.1M | $0.1M | $0.1M |
| Goodwill | $8.0M | $8.8M | $10.1M | $14.3M | $6.7M | $6.7M | $4.8M |
| Intangible assets | $6.6M | $6.0M | $7.1M | $13.4M | $11.0M | $5.4M | $3.4M |
| Total assets | $17.0M | $18.0M | $27.7M | $38.4M | $23.0M | $17.3M | $13.5M |
| Total liabilities | $16.4M | $18.1M | $53.7M | $29.5M | $15.9M | $14.3M | $7.1M |
| Preferred stock | $0.0M | $0.0M | β | β | β | β | β |
| Shareholders' equity | $0.7M | β$0.1M | β$26.1M | $8.9M | $7.1M | $3.0M | $6.4M |
| Margins | |||||||
| Operating margin | β69.7% | β49.7% | β30.0% | β55.9% | β101.1% | β54.8% | β72.5% |
| EBITDA margin | β53.4% | β31.5% | β13.4% | β34.2% | β82.1% | β42.0% | β61.8% |
| Net margin | β78.5% | β50.5% | β217.3% | 55.0% | β87.5% | β64.5% | β56.2% |
| FCF margin | β21.0% | β | β23.9% | β27.6% | β6.3% | β18.1% | β25.0% |
| Returns | |||||||
| Return on capital | β24.5% | β34.7% | β | β23.6% | β59.9% | β44.2% | β69.3% |
| Return on capital employed | β25.2% | β32.5% | 16.8% | β21.5% | β70.0% | β56.0% | β80.8% |
| Return on equity | β467.8% | β1,076.0% | β | β | β149.6% | β178.8% | β148.3% |
| Return on assets | β20.6% | β21.0% | β92.3% | 19.6% | β39.1% | β45.0% | β45.3% |
| Growth | |||||||
| Revenue growth | β | 64.0% | 33.1% | 21.1% | 16.7% | 2.3% | β11.6% |
| Net income growth | β | β | β | β | β285.7% | β | β |
| Share count change | β | 45.4% | β83.9% | 62.7% | β84.8% | 507.0% | 441.4% |
| Financial health | |||||||
| Debt / equity | 12.4x | β | β | 1.5x | 1.7x | 3.7x | 0.8x |
| Interest coverage | β | β | β | β | β | β | β8.6x |
| Current ratio | 0.1x | 0.2x | 0.2x | 0.4x | 1.4x | 1.1x | 1.8x |
| Quick ratio | 0.1x | 0.2x | 0.2x | 0.4x | 1.4x | 1.1x | 1.8x |
| Capital allocation | |||||||
| Capex / revenue | 12.6% | β | 0.7% | 0.5% | 0.2% | 0.2% | 0.1% |
| Stock comp / revenue | 23.5% | 20.2% | 7.7% | 10.6% | 6.4% | 3.8% | 38.8% |
| Quality scores | |||||||
| Piotroski F-score | β | 5.0 | 3.0 | 3.0 | 4.0 | 2.0 | 5.0 |
| Altman Z'' | β4.4 | β5.6 | β13.9 | β3.9 | β8.8 | β11.7 | β15.9 |
| Accruals ratio | β18.4% | β18.3% | β82.4% | 29.2% | β36.3% | β32.5% | β25.2% |
Source: SEC EDGAR XBRL filings (CIK 0001812727). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.